COFIX RX

Serial Number 90337951
734

Registration Progress

Application Filed
Nov 23, 2020
Under Examination
Jul 26, 2022
Approved for Publication
May 31, 2022
Published for Opposition
May 31, 2022
Registered

Trademark Image

COFIX RX

Basic Information

Serial Number
90337951
Filing Date
November 23, 2020
Published for Opposition
May 31, 2022
Drawing Code
5

Status Summary

Current Status
Active
Status Code
734
Status Date
Feb 25, 2025
Application
Pending
Classes
005 011

Rights Holder

CoFix-RX, LLC

16
Address
40900 Woodward Avenue Suite 111
Bloomfield Hills, MI 48304

Ownership History

CoFix-RX, LLC

Original Applicant
16
Bloomfield Hills, MI

CoFix-RX, LLC

Owner at Publication
16
Bloomfield Hills, MI

Legal Representation

Attorney
Michael G. Shariff

USPTO Deadlines

All Deadlines Cleared

All 7 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

48 events
Date Code Type Description Documents
Feb 25, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 25, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jan 27, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 27, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Jul 26, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 26, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 26, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 26, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 27, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 27, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 25, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 26, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Apr 26, 2024 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Apr 26, 2024 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Apr 26, 2024 PETG O PETITION TO REVIVE-GRANTED Loading...
Apr 26, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Feb 26, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Feb 26, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 26, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 26, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 26, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 26, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 26, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 26, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 26, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 26, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 31, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 31, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 11, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 25, 2022 ALIE A ASSIGNED TO LIE Loading...
Apr 22, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 6, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 6, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 6, 2022 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Oct 8, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 8, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 8, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
Sep 9, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 9, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 9, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 14, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 14, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 14, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 13, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 28, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 26, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances, used internally as pills and other solids, and also used as sprays and liquids for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; Pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; All-purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Nasal spray for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, spores
Class 011
Disinfectant apparatus for medical purposes; Disinfectant apparatus for medical purposes for killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Cleansing/sanitizing system comprising a containment enclosure specially adapted for containing an atomized cleansing/sanitizing spray mechanism for use in the cleansing/sanitizing of objects including articles of manufacture, natural products, foods and pharmaceuticals

Additional Information

Design Mark
The mark consists of the letter "CO" in large capital letters shaded in red and outlined in black followed by the word "Fix" in white and outlined in black with the letters "RX" dropped after the letter "x" in "Fix" with the letter "R" in red and a portion of the letter "X" in white both of which are outlined in black.
Color Claim
The color(s) red, black and white is/are claimed as a feature of the mark.
Pseudo Mark
CO FIX RX

Classification

International Classes
005 011